8 COVID-19 Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting COVID-19 Studies in San Francisco

NCT06667700Recruiting

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health condition...

San Francisco, CAPHASE33,082 participantsMerck Sharp & Dohme LLC

View Study Details

NCT04362150Recruiting

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

LIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a sp...

San Francisco, CA800 participantsUniversity of California, San Francisco

View Study Details

NCT06631287Recruiting

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertio...

San Francisco, CAPHASE3550 participantsWes Ely

View Study Details

NCT04815096Recruiting

Imaging Immune Activation in COVID-19

This is a single center, single arm exploratory imaging study involving up to two intravenous microdoses of \[18F\]F-AraG (the second tracer dose is optional) followed by whole-body PET-CT imaging in ...

San Francisco, CAPHASE280 participantsCellSight Technologies, Inc.

View Study Details

NCT06810934Recruiting

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

The goal of this clinical trial is to test two investigational COVID-19 booster vaccines, called CoTend-s3BXBB and CoTend-BXBB, in healthy volunteers ages 40-64. The CoTend-s3BXBB vaccine includes a c...

San Francisco, CAPHASE180 participantsKara Chew

View Study Details

NCT07076862Recruiting

Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)

This study uses total-body \[¹⁸F\]F-AraG PET/CT imaging to investigate immune activation and vascular changes in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC), also known as Long...

San Francisco, CAEARLY_PHASE151 participantsUniversity of California, Davis

View Study Details

NCT05530317Recruiting

CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19

The goal of this proof-of-concept clinical trial is to determine whether cardiac rehabilitation improves exercise capacity and chronotropic (heart rate) response to exercise among people with Long COV...

San Francisco, CANA20 participantsUniversity of California, San Francisco

View Study Details

NCT07108036Recruiting

A Study to Assess Anktiva in Patients With Long Covid-19.

This study will test the safety and tolerability of Anktiva in patients with Long Covid. Eligible patients will receive up to 2 doses of Anktiva and have follow-up exams and tests....

San Francisco, CAPHASE220 participantsImmunityBio, Inc.

View Study Details

About COVID-19 Clinical Trials in San Francisco

COVID-19 is an infectious disease caused by the SARS-CoV-2 virus that primarily affects the respiratory system. Long COVID (PASC) involves persistent symptoms weeks or months after initial infection. Treatment includes antiviral medications, monoclonal antibodies, and supportive care.

There are currently 8 covid-19 clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 4,683 participants. Research is being sponsored by Merck Sharp & Dohme LLC, University of California, San Francisco, Wes Ely and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

COVID-19 Clinical Trials in San Francisco — FAQ

Are there covid-19 clinical trials in San Francisco?

Yes, there are 8 covid-19 clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What covid-19 treatments are being tested?

The 8 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for covid-19.

Data updated July 17, 2026 from ClinicalTrials.gov